Botulinum Toxin Injections
J15
41 active Medicare policies list G43.E19, and 8 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
8 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of G43.E19 |
|---|---|---|
| Balloon Sinus Ostial Dilation | Jul 1, 2026 | Covered |
| Biofeedback and Neurofeedback | Jul 1, 2026 | Covered |
| Implantation of Occipital, Supraorbital or Trigeminal Nerve Stimulation Devices (and Related Procedures) | Oct 1, 2026 | Not covered |
| Occipital and Sphenopalatine Ganglion Nerve Block Therapy for the Treatment of Headache and Neuralgia | Oct 1, 2026 | Not covered |
| Surface Electrical Stimulation Devices for Headache and Migraine | Apr 15, 2026 | Covered |
| Surgical and Ablative Treatments for Chronic Headaches |
J5
J8 · Effective Feb 22, 2026
J9 · Effective Oct 1, 2015
JH · Effective Mar 21, 2021
JL · Effective Mar 21, 2021
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
J9 · Effective Nov 9, 2025
JH · Effective Nov 9, 2025
National · Effective Apr 9, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 23, 2025
J9 · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
| Apr 15, 2026 |
| Not covered |
| Policy | Effective | Status of G43.E19 |
|---|---|---|
| Visual Field Testing | Not recorded | Covered |
| Policy | Effective | Status of G43.E19 |
|---|---|---|
| Peripheral Nerve Destruction for Pain Conditions | Sep 15, 2026 | Not covered |